Catalyst Pharmaceuticals (NASDAQ: CPRX) is having an incredibly rough day in the market today, giving up as much as 40% of its value early on… Read More »Catalyst Pharmaceuticals (CPRX) Stock: Why Today’s Declines May Be A Big Opportunity
Biotech Stock News
With the recent gains seen out of ARCA Biopharma (NASDAQ: ABIO) (Full ABIO Report Here), investors are starting to look for other investment opportunities in… Read More »InspireMD (NSPR) Stock: A Strong Play In Cardiovascular Health
Precipio (NASDAQ: PRPO) is up more than 8% this morning after reminding investors of a coming conference call. The call is scheduled to take place… Read More »Precipio (PRPO) Stock: Could Soar Following Conference Call
ARCA Biopharma (NASDAQ: ABIO) traded with gains well over 100% in the session today after announcing that its data was published in a peer reviewed… Read More »Arca Biopharma (ABIO) Stock: Why You May Want To Consider Jumping In!
Novan Inc (NASDAQ: NOVN) is soaring in the market today with mid-day gains as high as 65%. The gains follow the company’s announcement that it… Read More »Novan (NOVN) Stock: Rocketing On Non-Dilutive Funding
Hemispherx Biopharma (NYSEAMERICAN: HEB) is having a great day in the market today after announcing positive clinical data. While the data was what brought the… Read More »Hemispherx Biopharma (HEB) Stock: The Potential Here Is Incredible
Precipio, Inc. (NASDAQ: PRPO) had a strong trading session in the market today, gaining 5% throughout the day and an additional 1.39% after hours. The… Read More »Precipio (PRPO) Stock: Early International Success Expands Value
Achaogen Inc (NASDAQ: AKAO) is rocketing in the market this today, gaining as much as 62.92%. With no news out, many are wondering what’s going… Read More »Achaogen (AKAO) Stock: Now May Be The Time To Get Involved
I published a detailed report about Precipio Inc (NASDAQ: PRPO) on April 9, 2019, just a couple of weeks ago. Those who read the report… Read More »Precipo (PRPO) Stock: The Story Just Keeps Getting Better
Atossa Genetics Inc (NASDAQ: ATOS) is a stock that crossed my radar a few months ago, and I’ve been impressed as I’ve dug in. It… Read More »Atossa Genetics (ATOS) Stock: Gearing Up For Strong Growth Ahead
TrovaGene Inc (NASDAQ: TROV) is having a great start to the trading session this morning, trading up more than 18% after announcing positive preclinical data… Read More »TrovaGene (TROV) Stock: Making A Run On New Data
Moleculin Biotech Inc (NASDAQ: MBRX) has been climbing in the market over the past couple of trading sessions, with gains of more than 30% today… Read More »Moleculin Biotech (MBRX) Stock: Why Now May Be The Time To Get Involved
Precipio Inc (NASDAQ: PRPO) is a company that I’ve been following closely as of late. For those of you that haven’t gotten familiar with the… Read More »Precipio (PRPO) Stock: This Update Could Change The Game!
Rexahn Pharmaceuticals, Inc. (NYSEAMERICAN: RNN) has been on my watch list for some time now. However, I haven’t dug in too deep as I was… Read More »Rexahn Pharmaceuticals (RNN) Stock: It’s Time To Give This Some Thought!
Amyris Inc (NASDAQ: AMRS) is having an overwhelmingly rough day in the market today, trading down 21.07% at the time of writing this article. While… Read More »Amyris (AMRS) Stock: Buy The Dip, Thank Me Later!
Avinger Inc (NASDAQ: AVGR) is having a strong day in the market today, gaining more than 12% after announcing an FDA 510(k) clearance. With the… Read More »Avinger (AVGR) Stock: Recent News Makes This A Strong Buy!
Precipio Inc (NASDAQ: PRPO) has been a big topic of conversation as of late, and for good reason. After announcing positive news from on client… Read More »Precipio (PRPO) Stock: Why It’s Time To Jump In Head First!
Novavax, Inc. (NASDAQ: NVAX) has been an interesting stock to follow as of late. After trading in the low-to-mid $2 range early on in the… Read More »Novavax (NVAX) Stock: Is Now The Time To Jump In?
TrovaGene Inc (NASDAQ: TROV) has been a hot topic of discussion among the biotech investing community as of late. With consistent news releases coming out… Read More »TrovaGene (TROV) Stock: Is Now The Time To Dive In?
Amarin Corporation plc (NASDAQ: AMRN) is seeing quite a bit of after-hours chatter this evening. According to various posts on message boards and social media,… Read More »Amarin Corporation (AMRN) Stock: Worth Considering Regardless Of Rumors